Skip to Content

Join the 'Glaucoma (Open Angle)' group to help and get support from people like you.

Glaucoma (Open Angle) Support Group

Summary

Our support group for Glaucoma (Open Angle) has 50 questions and 42 members. Updated 22 Jan 2018.

Popular Questions

View more questions...

Further Information

Related Condition Support Groups

Glaucoma

Related Drug Support Groups

latanoprost, Lumigan, Travatan, Xalatan, Travatan Z, Alphagan, Cosopt, Azopt, brimonidine, view more... dorzolamide, Zioptan, Alphagan P, Timoptic, Trusopt, travoprost, Betagan, Simbrinza, brinzolamide, bimatoprost, Pilopine-HS, Rescula, Cosopt PF, Timoptic Ocudose, Rhopressa, dorzolamide / timolol, dipivefrin, tafluprost, levobunolol, OptiPranolol, Ocupress, Epinal, Timoptic-XE, Betimol, unoprostone, Betoptic, Betoptic-S, AK-Beta, metipranolol, Epifrin, Betaxon, levobetaxolol, Izba, Qoliana, Vyzulta, Eppy / N, Piloptic-6, Glaucon, Pilagan with C Cap, Isopto Carpine, Pilocar, Istalol, netarsudil, latanoprostene bunod, brimonidine / brinzolamide, AK-Pro, Adsorbocarpine, Ocu-Carpine, Propine, Ocusert, Piloptic-1 / 2, Pilostat, Piloptic-1, Akarpine, Piloptic-2, Piloptic-3, Piloptic-4, Betagan C-Cap

Related Condition Guides

Search this Group

Latest News

Aerie Pharmaceuticals Announces U.S. FDA Approval of Rhopressa (netarsudil ophthalmic solution) 0.02% for Patients with Open-Angle Glaucoma or Ocular Hypertension

IRVINE, Calif.--(BUSINESS WIRE)--Dec. 18, 2017-- Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), an ophthalmic pharmaceutical company focused on the discovery, development, and ...

Read more news...

Latest Questions

View more questions...

Top Group Members

Marvell
14,356 total answers
In this group:
8 answers
suzanne66
11,190 total answers
In this group:
8 answers
coloresue
1,080 total answers
In this group:
3 answers
Robert tr8
25 total answers
In this group:
3 answers
Rajive G...
6,060 total answers
In this group:
2 answers
Srr1111
466 total answers
In this group:
1 answer

View all 42 members...

Ask a Question